CRISPR-Cas9 Genomic Editing As an Innovation in the Management of Sickle Cell Disease: A Systematic Review. Am. J. Med. Sci. Innov. 2023, 2 (2), 44-56. https://doi.org/10.54536/ajmsi.v2i2.1760.